Join us for our third IRD Invest virtual investor conference to hear from a range of Australian listed companies that are innovating by addressing evolving consumer needs.
Registration for the event is FREE – see below for full details.
PRESENTERS: Wednesday 22nd September
John Kelly, Founder, Managing Director & CEO and Will Souter, Chief Financial Officer, Atomo Diagnostics (ASX: AT1)
Atomo is an Australian medical device company supplying unique, integrated rapid diagnostic test (RDT) devices to the global diagnostic market. Atomo’s patented devices simplify testing procedures and enhance usability for professional users and untrained self-testers.
11.00 – 11.25am
Dr Chris Hart, Founder and CEO, Oventus Medical Limited (ASX: OVN)
Oventus is a Brisbane-based medical device company that is commercialising a unique treatment platform for obstructive sleep apnea (OSA) and snoring. The Company has a collaborative Sleep Physician/Dental strategy that streamlines patients’ access to treatment.
11.30 – 11.55am
Michael Eidel, Group Chief Executive Officer and Managing Director, Openpay Group Ltd (ASX: OPY)
Openpay Group Ltd (ASX: OPY) is a fast-growing and highly differentiated player in the global 'Buy now pay later' (BNPL) payment solutions market.
12.00 – 12.25pm
Oliver Horn, Executive Director and Global CEO, Elixinol Wellness Limited (ASX:EXL)
Elixinol Wellness Limited (ASX:EXL; OTCQB:ELLXF) is a global leader in the hemp industry, innovating, marketing and selling hemp derived nutraceutical, cosmetic and food products.
12.30 – 12.55pm
Martin Filz, Chief Executive Officer, Pureprofile Ltd (ASX: PPL)
Pureprofile Limited (ASX: PPL) connects brands with empowered customers across the world by finding, understanding and engaging them through direct-to-consumer technology platforms.